إعلان
إعلان

DGX

DGX logo

Quest Diagnostics Inc.

174.44
USD
برعاية
-3.25
-1.83%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

قبل الإفتتاح

174.45

+0.01
+0.01%

تقارير أرباح DGX

النسبة الإيجابية المفاجئة

DGX تفوق 33 من 39 آخر التقديرات.

85%

التقرير التالي

بيانات التقرير القادم
٢٩ يناير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$2.78B
/
$2.38
التغير الضمني من Q3 25 (Revenue/ EPS)
-1.25%
/
-8.46%
التغير الضمني من Q4 24 (Revenue/ EPS)
+6.10%
/
+2.15%

Quest Diagnostics Inc. earnings per share and revenue

On ٢١ أكتوبر ٢٠٢٥, DGX reported earnings of 2.60 USD per share (EPS) for Q3 25, beating the estimate of 2.52 USD, resulting in a 2.81% surprise. Revenue reached 2.82 مليار, compared to an expected 2.76 مليار, with a 1.89% difference. The market reacted with a -3.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 المحللين forecast an EPS of 2.38 USD, with revenue projected to reach 2.78 مليار USD, implying an نقصان of -8.46% EPS, and نقصان of -1.25% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Quest Diagnostics Inc. reported EPS of $2.60, beating estimates by 2.81%, and revenue of $2.82B, 1.89% above expectations.
The stock price moved down -3.03%, changed from $190.41 before the earnings release to $184.64 the day after.
The next earning report is scheduled for ٢٩ يناير ٢٠٢٦.
Based on 18 المحللين, Quest Diagnostics Inc. is expected to report EPS of $2.38 and revenue of $2.78B for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان